White Paper The High Bar for Gene Therapy CMC How drug developers can step up to meet regulatory expectations for gene therapy chemistry...
Read more
Resources
How the Industry’s Pandemic Response Opened the Door to Therapeutic Opportunities
The biopharma industry was certainly not immune to the turbulence brought about by the COVID-19 pandemic. The pandemic disrupted — and in some...
Read more
Viral Clearance Studies for Gene Therapies—Easier Said Than Done
While incidents of biotherapeutic viral contamination have occurred, due to well-established knowledge of the potential sources of...
Read more
Gene and Cell Therapy Developers Are Getting Creative to Keep Programs on Track During the Pandemic
Jeanette Young, senior consultant for analytical services at BioTechLogic talks with Tonia Becker, Life Sciences Editor, Macon Raine As it...
Read more
Lessons from the Pandemic and Addressing Gene Therapy Process Development Challenges
It’s a fascinating time to be in the biotherapeutics industry. What will the remarkedly rapid COVID-19 vaccine development effort teach us...
Read more
Gene Therapy CMC & Manufacturing Approaches Are Maturing
The gene therapy sector is maturing and the industry is poised to be able to produce products in more consistent and scalable ways. Although...
Read more